Financial toxicity, Part I: a new name for a growing problem.
Financial toxicity, Part I: a new name for a growing problem.
复制标题
作者：
S. Y. Zafar;A. Abernethy
医疗费用继续上升；新的抗癌药物比以往任何时候都更昂贵，越来越多的患者正在接受这些药物的治疗。虽然患者和索赔数据集一致地报告了经济负担和护理质量之间的关联，但尚未评估对传统疾病相关结果--例如生存--的影响。
Costs of care continue to rise; new cancer drugs are more expensive than ever before, and more patients are being treated with these drugs. While patients and claims datasets consistently report an association between financial burden and quality of care, the impact on traditional disease-related outcomes—survival, for example—have not been assessed.